AgaMatrix Gets $1.3M Fees From Dexcom's Failed IP Suit

By Dani Kass (August 7, 2018, 7:39 PM EDT) -- A California federal judge has ruled that diabetes glucose monitoring company Dexcom Inc. must pay rival AgaMatrix Inc. more than $1.3 million in fees after proceeding with patent infringement litigation that bordered on bad faith....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Read the full article

Already a subscriber? Click here to login